NEWSpublisher 2007 :: AngloChinese Investments
SEARCH COMPANY
name:
trunover in millions USD:
from:    to: 
R & D turnover in millions USD:
from:     to: 
NET profit:
from:    to: 
employees:
from:    to: 
COMPANIES
APPROVALS
ACTIVITIES ENGAGED IN
R & D
CLINICAL TRIALS
NON CLINICAL & PRECLINICAL
CHEMISTRY-CONTRACT MANUFACTURE
TEST
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY DETAILS » Johnson & Johnson back to previous page show list

Johnson & Johnson

address: 1 Johnson & Johnson Plaza
contact:
key person: William C. Weldon, Chairman & CEO
Dominic J. Caruso, CFO,
Christine A. Poon, Vice Chairman & Worldwide Chairman Medicines & Nutritionals

trunover in millions USD: 61
R & D turnover in millions USD: 8
NET profit: 12100
year of financial results: 2007
employees: 116200

active in China: YES

SFDA approved: NO

Approvals:
GLP: NO
GMP: NO
AAALAC: NO
SEPA: NO

Activities engaged in:
Manufacture: NO
Active Pharmaceutical: NO
R&D: NO
Ingredients: NO
Western Generics: NO
TCM: NO

R & D:
Discovery: NO
Work Up (pilot to production): NO
Analysis: NO
Quality Control: NO
Stability: NO
Batch Release: NO

Clinical trials:
Run/Manage: NO
Data management: NO
Support Labs: NO

Non clinical & preclinical:
Animal Testing: GLP: NO
New materials Safety Assessment: NO
Pharmaceuticals: NO
Agrochemicals: NO
Industrial & Other Chemicals: NO
Non GLP - Discovery ADME: NO

Chemistry-contract manufacture:
Generics: NO
API: NO
Licensed Drugs: NO

test:
R&D: NO
 

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. They have put into place three major Research & Development processes; Drug Evaluation and Global Development. These processes maximize all aspects of global research, development and marketing. Within these processes they have also created a new paradigm for quality, quantity and speed by taking advantage of emerging technologies.

The employees of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. are committed to scientific excellence, though leadership, and innovation. They perform worldwide research and development work for the pharmaceutical business units of Johnson & Johnson worldwide. Although they are located on nine campuses in the United States and Europe, their reach is truly global: they support patients in over 70 countries.

They mission is to "To enhance the health of people worldwide by creating innovative pharmaceutical products for Johnson & Johnson." Their objective is to discover and to develop new drugs and delivery systems that provide significant advances in the treatment or prevention of human diseases, and reduce patient morbidity or mortality, treat serious or inadequately treated diseases, improve the economics of patient care

Innovation in drug discovery and development, as well as advancements in biotechnology, make the company a significant contributor of new products for the treatment of human diseases and thus, the enhancement of health.

First and foremost their success as a business is a direct product of our commitment to people - their patients, doctors, nurses, customers, employees, community and stockholders. Their Credo was written by Robert Wood Johnson and continues to embody our ethical standards of leadership in all areas of endeavor. The Credo, which is studied in business ethics courses throughout the world, sets forth the values by which we live: trustworthiness, respect, accountability, fairness, caring, and community responsibility.

At Johnson & Johnson Pharmaceutical Research & Development, L.L.C. helping people and living the Johnson & Johnson Credo are ways of life.

Johnson & Johnson in China 
  • Xian-Janssen Pharmaceutical Ltd. in 19
  • Johnson &Johnson (China)Ltd.—Shanghai in 1992
  • Johnson &Johnson Medical (China)Ltd.—shanghai 1994
  • Shanghai Johnson &Johnson Pharmaceuticals Ltd.
  • Johnson &Johnson Vision Care (Shanghai) Limited.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.